ClinicalTrials.Veeva

Menu

Effect of High Flow Nasal During Exercise in COPD Patients (AiRehab)

G

Groupe Hospitalier du Havre

Status

Completed

Conditions

COPD Exacerbation

Treatments

Device: High Flow nasal cannula

Study type

Interventional

Funder types

Other

Identifiers

NCT03058081
2016-A01325-46

Details and patient eligibility

About

Early pulmonary rehabilitation is recommended after an episode of severe exacerbation of chronic obstructive pulmonary disease (COPD). However, its implementation is challenging particularly as regard exercise training. High flow ventilation in reducing work of breathing and dyspnea may improve exercise tolerance. The aim of this study is to carry out the acute effect of high flow nasal cannula on exercise endurance in post-exacerbation copd patients

Enrollment

19 patients

Sex

All

Ages

35 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • a diagnosis of COPD

Exclusion criteria

  • exercise contraindication Any musculoskeletal problems, cardiovascular or neurological comorbidities that limits exercise.
  • pH < 7,35
  • Body temperature > 38°C
  • cardiac frequency > 100 bpm at rest
  • systolic blood pressure < 100 mmHg
  • exacerbation during the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

19 participants in 2 patient groups

High Flow Nasal Test
Experimental group
Description:
Patients will perform one Constant Work-Rate Exercise Test at 80% of maximum workload with High Flow Nasal at 60L/min (with or without additional oxygen)
Treatment:
Device: High Flow nasal cannula
Control Test
No Intervention group
Description:
Patient will perform one Constant Work-Rate Exercise Test at 80% of maximum workload on room air or with oxygen supplementation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems